2022
DOI: 10.1089/omi.2022.0090
|View full text |Cite
|
Sign up to set email alerts
|

Worldwide Systematic Review of GSTM1 and GSTT1 Null Genotypes by Continent, Ethnicity, and Therapeutic Area

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 93 publications
0
11
1
Order By: Relevance
“…Also, it was reported that women who are HPV-positive and who carry both null genotypes present an increased risk of cervical carcinoma developing before the age of 40 years [69]. Our results do not show an association of GSTM1 or double mutants with cervical cancer or precursor lesions; GST-null mutants have been reported to be associated with oncologic diseases in general, though [70].…”
Section: Discussioncontrasting
confidence: 75%
“…Also, it was reported that women who are HPV-positive and who carry both null genotypes present an increased risk of cervical carcinoma developing before the age of 40 years [69]. Our results do not show an association of GSTM1 or double mutants with cervical cancer or precursor lesions; GST-null mutants have been reported to be associated with oncologic diseases in general, though [70].…”
Section: Discussioncontrasting
confidence: 75%
“…otype may be associated with susceptibility to certain tumors [45,48]. In our study, we found that the proportion of individuals with GSTT1 polymorphisms (present) in thyroid cancer patients was lower than that in the normal control group, but without statistical significance (Mean difference = 1.10, 95 % CI: 0.89-1.36, p = 0.37).…”
Section: Discussionmentioning
confidence: 48%
“…Literature reports have shown that the distribution of the GSTM1 null genotype frequency differs among different ethnic groups and populations in different regions [44]. In Western populations, the frequency of the GSTM1 null genotype is approximately 31-58 % [45]. In this study, the proportion of GSTM1 polymorphisms (present) in thyroid cancer patients was slightly lower than that of the normal control group, but without statistical significance (Mean difference = 0.85, 95 % CI: 0.71-1.01, p = 0.06).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many of them are characterized by genetic polymorphism that affects the functional activity of their alleles. There is evidence that the null allele of glutathione-S-transferase, which has an extended deletion, is associated with lung cancer, bladder cancer, breast cancer, and the development of endometriosis [ 14 ]. Many case-control studies revealed the associations of single nucleotide polymorphisms (SNPs) of genes participating in xenobiotic detoxification and antioxidant protection with a broad spectrum of multifactorial diseases.…”
Section: Introductionmentioning
confidence: 99%